# Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals

> **NCT03711318** · PHASE3 · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 8 (actual)

## Conditions studied

- Heroin Dependence

## Interventions

- **DRUG:** Buprenorphine/naloxone

## Key facts

- **NCT ID:** NCT03711318
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** continuing study was no longer feasible
- **Last updated:** 2022-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03711318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03711318, "Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03711318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*